Aveo to receive $25M as OSI exercises option

OSI Pharmaceuticals Inc. exercised an option for a non-exclusive license to the Human Response Platform technology from Aveo Pharmaceuticals Inc. (NASDAQ:AVEO), triggering $25 million in milestone pay...